Join to View Full Profile
9200 W Wisconsin AveMilwaukee, WI 53226
Phone+1 414-805-4600
Fax+1 414-805-6815
Dr. Runaas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MichiganFellowship, Hematology and Medical Oncology, 2014 - 2017
University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 2010 - 2013
University of Wisconsin School of Medicine & Public HealthClass of 2010
Certifications & Licensure
WI State Medical License 2012 - 2025
MI State Medical License 2014 - 2018
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Tildrakizumab for Prevention of Acute Graft-Versus-Host Disease Start of enrollment: 2020 Mar 01
Publications & Presentations
PubMed
- Novel Composite Health Assessment Risk Model for Older Allogeneic Transplant Recipients: BMT-CTN 1704.Mohamed L Sorror, Wael Saber, Brent R Logan, Nancy L Geller, Anna Bellach
Blood Advances. 2025-03-18 - Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703.Shernan G Holtan, Javier Bolaños-Meade, Monzr M Al Malki, Juan Wu, Carrie L Kitko
Journal of Clinical Oncology. 2025-03-10 - Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant.Steven J Siegel, Susan DeWolf, Joseph Schmalz, Wael Saber, Jiayi Dong
Medrxiv. 2025-02-26
Abstracts/Posters
- A Multisite Phase Ib Study of Pevonedistat, Azacitidine and Venetoclax (PAVE) for the Treatment of Subjects with Acute Myelogenous Leukemia (AML)Lyndsey Runaas, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Lintuzumab Ac-225 in Combination with CLAG-M Chemotherapy in Relapsed/Refractory AML: Interim Results of a Phase I StudyLyndsey Runaas, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Systematic Screening for Familial Leukemia Based on Somatic Genomic Profiling Results2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Reducing Venous Thrombosis with Antithrombin Supplementation in Patients Undergoing Treatment for ALL with Asparaginase Based Regimens2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
